Landes Bioscience Journals: Cell Cycle

In this issue

Cell Cycle

Volume 9, Issue 17
September 1, 2010
View current issue

About the cover

Confocal microscopy photograph of human keratinocytes that are stained for cyclin D1 (red), Actin (green) and Dapi (blue). For more information see Edel et...
Continue reading

Issue Highlights

Four key studies conducted by a large team of researchers led by Dr. Michael Lisanti explain how and why cancer cells grow and survive. This is a major step in cancer research as it allows researchers to design better diagnostics and therapies to target high-risk patients.

For the press release, click here. You may also access the research papers directly in the current issue of Cell Cycle.

Sign up for Table of Contents Alerts

Submit your paper to Cell Cycle

Cell Cycle utilizes an online submission and tracking system designed to provide efficient service to authors. Through the online system, author files are automatically converted to PDFs, submissions are acknowledged by email, and authors can track their manuscript through the stages of the peer review process.

There are 3 submission tracks to choose from:

Editor-in-Chief

M.V. Blagosklonny, M.D., Ph.D.
Roswell Park Cancer Institute
Buffalo, NY

Email the Managing Editor.

Print ISSN: 1538-4101
Online ISSN: 1551-4005 DOI: 10.4161/cc

About Cell Cycle

In addition to the cell cycle and cell division, Cell Cycle covers all topics from man to virus, from DNA to RNA, from aging to development, from cell senescence to stem cells, from apoptosis to autophagy, from cancer to neurobiology, from molecular and theoretical biology to medicine and therapy.

Cell Cycle is indexed in Medline/PubMed and in the Science Citation Index Expanded.

2009 Impact Factor: 4.087
Total Cites: 8938
Articles in 2009: 503

Most Popular Downloads

15 Aug 10

AKT-ing via microRNA
Danish Sayed and Maha Abdellatif

15 Jul 10

Signaling pathways in the epithelial origins of pulmonary fibrosis
William D. Hardie, James S. Hagood, Vrushank Dave, et al.

15 Aug 10

Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells
Ubaldo Martinez-Outschoorn, Renee Balliet, Dayana Rivadeneira, et al.

Scooped?

If your lab's work was recently scooped by a paper in Cell, Nature or Science, please contact us for ultra-rapid peer-review and publication

HINARI

Landes Bioscience gladly participates in the World Health Organization's Access to Research Initiative (HINARI) to provide free online access to all papers published in Cell Cycle to scientists in developing countries worldwide.

Dr. Mikhail V. Blagosklonny, Editor-in-Chief of Cell Cycle, joins the Roswell Park Cancer Institute

As of April 15, 2009, Mikhail (Misha) Blagosklonny, MD, PhD (pictured right), has been appointed Member/Professor of Oncology in the Department of Cell Stress Biology at Roswell Park Cancer Institute, Buffalo, NY. Dr. Blagosklonny is the author of over 170 research articles, reviews and book chapters. He is the Editor-in-Chief of Cell Cycle and also serves as an Associate Editor for Cancer Biology & Therapy, Autophagy, Cancer Research, Cell Death and Differentiation, International Journal of Cancer, The American Journal of Pathology and PLOS ONE. His research interests range from molecular and cellular biology to clinical investigations and include signal transduction, cell cycle, cellular senescence, and anticancer therapeutics with an emphasis on translation of basic science into new anticancer strategies. He extended the study of signal transduction pathways from cancer to aging, revealing potential targets for slowing down aging and age-related diseases. “Misha is a pre-eminent researcher, who developed unique concepts on cancer biology and therapy ,” according to Andrei V. Gudkov, Senior Vice-President of Basic Science at Roswell Park and Chairman of the Department of Cell Stress Biology (pictured left). “The presence of Misha will facilitate the development of new anti-cancer strategies and methods of cancer therapy and prevention. Here at Roswell, we are very enthusiastic about his recruitment. We share numerous ideas and approaches, including protection of normal cells from radio- and chemotherapy, selective combinations of anticancer drugs, tissue-specific therapy (anti-tissue therapy) of cancer, and prevention of cancer by slowing down organismal aging”.

Select Submission Track: Cell Cycle will reconsider papers rejected by Science, Nature, Cell and others.

Cell Cycle recognizes that excellent papers may have been erroneously rejected by other journals. We will reconsider papers that have been rejected by Nature, Science, Nature Medicine, Nature Cell Biology, Cell, Cancer Cell, Cell Metabolism, Developmental Cell, NEJM, Lancet, Genes & Development and some other journals in the original format of those journals, thus saving the authors effort and time. The authors are encouraged to enclose the reviewers' and/or editorial comments from the above mentioned journals. This will certainly expedite the evaluation of the article and it is possible the article might be accepted based on its previous review. This will allow the urgent and competitive research to be published in a timely manner. You may submit your paper online. Following submission, please contact Yelena Boryskina, Assitant to the Editor-in-Chief, with the manuscript number and copies of the previous reviews. If you have questions, you may also contact Dr. Blagosklonny, the Editor-in-Chief, directly.